Cap-dependent endonuclease inhibitors (CENis) - NHRC
| Agency: | DEPT OF DEFENSE |
|---|---|
| State: | Texas |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Set Aside: | No Set aside used |
| Posted Date: | May 26, 2026 |
| Due Date: | May 28, 2026 |
| Solicitation No: | N0018926QB059 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
- Updated Published Date: May 26, 2026 01:16 pm EDT
- Original Published Date: May 15, 2026 02:47 pm EDT
- Updated Date Offers Due: May 28, 2026 05:00 pm EDT
- Original Date Offers Due: May 25, 2026 05:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Updated Inactive Date: Jun 12, 2026
- Original Inactive Date: Jun 09, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
-
NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
Galveston , TXUSA
The preclinical development of Cap-dependent endonuclease inhibitors (CENi), a class of small molecules, as broad-spectrum antiviral therapeutics. The scope of this project includes all activities required to select lead CENi candidates, including in vitro and in vivo efficacy studies and characterization and optimization of lead compounds. This includes Research Support expertise regarding the preclinical development of cap-dependent endonuclease inhibitors (CENis) with viruses that require biosafety level 4 (BSL-4) containment to support the Naval Medical Research Command in Fort Detrick, MD. This work will be performed over a 36-month period.
- ATTENTION CODE 301 1968 GILBERT STREET SUITE 600
- NORFOLK , VA 23511-3392
- USA
- Brian Kinkade
- brian.m.kinkade.civ@us.navy.mil
- Phone Number 7712292412
- Jacob Gephart
- jacob.n.gephart.civ@us.navy.mil
- Phone Number 7712292712
- May 26, 2026 01:16 pm EDTCombined Synopsis/Solicitation (Updated)
- May 15, 2026 02:47 pm EDT Combined Synopsis/Solicitation (Original)
Related Document
| May 15, 2026 | [Combined Synopsis/Solicitation (Original)] Cap-dependent endonuclease inhibitors (CENis) - NHRC |
See Also
RFP 27.02-After School Enrichment Services RFP 27.02-After School Enrichment Services Exhibit A-Project Specifications
Beaumont Independent School District
Due by 12/17/2026
Follow Venous Thrombosis (VT) Active Contract Opportunity Notice ID 80JSC026Q0014 Related Notice Department/Ind.
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
Due by 11/20/2026
Bid Number Bid Title Bid Type Organization Bid Issue Date Bid Close Date
North East Independent School District
Due by 11/30/2027
Follow AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING Active Contract Opportunity Notice ID
DEPT OF DEFENSE
Due by 9/30/2027